SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,989,000 | -69.2% | 180,979 | -60.4% | 0.02% | -65.8% |
| Q4 2021 | $19,462,000 | +15.8% | 457,580 | +20.7% | 0.07% | +14.1% |
| Q3 2021 | $16,801,000 | +46.3% | 379,245 | +87.6% | 0.06% | +48.8% |
| Q2 2021 | $11,483,000 | +64.9% | 202,143 | +117.2% | 0.04% | +59.3% |
| Q1 2021 | $6,965,000 | +22367.7% | 93,050 | +25819.2% | 0.03% | – |
| Q4 2020 | $31,000 | +19.2% | 359 | -41.5% | 0.00% | – |
| Q2 2020 | $26,000 | – | 614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |